Table 2 Inflammatory markers and new coronary events (NCE) in six months and one year of follow up.
| Marker | 0–6 months | p Value | 0–1 year | p Value | ||
|---|---|---|---|---|---|---|
| NCE− (n = 61) | NCE+ (n = 19) | NCE− (n = 57) | NCE+ (n = 23) | |||
| hs‐CRP (μmol/l) | 62 (97) | 115 (106) | 0.01 | 53 (88) | 106 (106) | 0.05 |
| IL‐1β (pg/ml) | 0.6 (1.7) | 1.2 (1.9) | 0.01 | 0.7 (1.7) | 1.1 (1.8) | 0.04 |
| IL‐6 (pg/ml) | 4.4 (3.4) | 5.9 (3.3) | 0.1 | 4.3 (3.4) | 6.0 (0.2) | 0.03 |
| TNFα (pg/ml) | 11 (13) | 8.4 (8.5) | 0.6 | 12 (13) | 8.9 (8.7) | 0.4 |
| IL‐10 (pg/ml) | 8.7 (7.4) | 5.6 (3.8) | 0.08 | 8.5 (7.1) | 6.5 (6.2) | 0.1 |
Data are presented as mean (SD).
hs‐CRP, high sensitivity C‐reactive protein; IL, interleukin; TNF, tumour necrosis factor.